SPOTLIGHT: GSK prepares pipeline update

Analysts are keenly awaiting tomorrow's presentation by GlaxoSmithKline on its brightest pipeline hopes. GSK is betting that its experimental vaccines -- like Cervarix -- can rev up its bottom line. Story